Items where authors include "Down, J.M."

Article

Lefley, D.V., Jones, C.G. orcid.org/0000-0003-2958-8322, Zhou, J. et al. (5 more authors) (2025) ATM inhibition increases the anti-tumor efficacy of radium-223 (Ra-223) against prostate cancer bone metastasis in preclinical models. JBMR Plus, 9 (10). ziaf129. ISSN 2473-4039

Zhou, J. orcid.org/0000-0003-1108-6391, Down, J.M., George, C.N. et al. (6 more authors) (2022) Novel methods of targeting IL-1 signalling for the treatment of breast cancer bone metastasis. Cancers, 14 (19). 4816.

Tattersall, L. orcid.org/0000-0001-8835-0627, Shah, K.M. orcid.org/0000-0001-9909-6409, Lath, D.L. et al. (11 more authors) (2021) The P2RX7B splice variant modulates osteosarcoma cell behaviour and metastatic properties. Journal of Bone Oncology, 31. 100398.

Crawford, L.J., Campbell, D.C., Morgan, J.J. et al. (10 more authors) (2020) The E3 ligase HUWE1 inhibition as a therapeutic strategy to target MYC in multiple myeloma. Oncogene, 39 (27). pp. 5001-5014. ISSN 0950-9232

Green, A.C. orcid.org/0000-0002-0175-1485, Lath, D. orcid.org/0000-0001-5454-9419, Hudson, K. et al. (8 more authors) (2019) TGFβ inhibition stimulates collagen maturation to enhance bone repair and fracture resistance in a murine myeloma model. Journal of Bone and Mineral Research, 34 (12). pp. 2311-2326. ISSN 0884-0431

Paton-Hough, J., Tazzyman, S., Evans, H. et al. (6 more authors) (2019) Preventing and repairing myeloma bone disease by combining conventional antiresorptive treatment with a bone anabolic agent in murine models. Journal of Bone and Mineral Research, 34 (5). pp. 783-796. ISSN 0884-0431

Lath, D.L. orcid.org/0000-0001-5454-9419, Buckle, C.H., Evans, H.R. et al. (4 more authors) (2018) ARQ-197, a small-molecule inhibitor of c-Met, reduces tumour burden and prevents myeloma-induced bone disease in vivo. PLoS One, 13 (6). e0199517. ISSN 1932-6203

Chai, R.C., McDonald, M.M., Terry, R.L. et al. (12 more authors) (2017) Melphalan modifies the bone microenvironment by enhancing osteoclast formation. Oncotarget, 8 (40). pp. 68047-68058. ISSN 1949-2553